Selective chemoembolization in the management of hepatic metastases in refractory colorectal carcinoma: A phase II trial

Diseases of the Colon and Rectum

Volumn 40, Issue 7, 1997, Pages 770-775

  Sanz Altamira, Pedro M ^a   Spence, Liam D ^a   Huberman, Mark S ^a   Posner, Marshall R ^a   Steele Jr , Glenn ^b   Perry, Laura J ^a   Stuart, Keith E ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c Division of Hematology Oncology   (United States)

Author keywords

5 Fluorouracil; Chemoembolization; Colorectal carcinoma; Ethiodized oil; Gelfoam; Liver metastases; Mitomycin C

Indexed keywords

ALKALINE PHOSPHATASE; CARCINOEMBRYONIC ANTIGEN; ETHIODIZED OIL; FLUOROURACIL; GELFOAM; LACTATE DEHYDROGENASE; MITOMYCIN C;

ABDOMINAL PAIN; ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ANGIOGRAPHY; ARTICLE; ARTIFICIAL EMBOLISM; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; FATIGUE; FEMALE; FEVER; GALLBLADDER DISEASE; HEPATIC ARTERY; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER METASTASIS; MALE; PERITONITIS; PHASE 2 CLINICAL TRIAL; PROGNOSIS; SEPSIS; SURVIVAL TIME;

ABDOMINAL PAIN; ADULT; AGED; ALKALINE PHOSPHATASE; ANGIOGRAPHY; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; CARCINOMA; CHEMOEMBOLIZATION, THERAPEUTIC; COLONIC NEOPLASMS; ETHIODIZED OIL; FATIGUE; FEMALE; FEVER; FLUOROURACIL; FOLLOW-UP STUDIES; GELATIN SPONGE, ABSORBABLE; HEMOSTATICS; HEPATIC ARTERY; HUMANS; L-LACTATE DEHYDROGENASE; LIVER NEOPLASMS; MALE; MIDDLE AGED; MITOMYCIN; PROGNOSIS; RECTAL NEOPLASMS; SURVIVAL RATE;

EID: 0030847236     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02055430     Document Type: Article

References (26)

1. Weiss L, Grundmann E, Torhorst J, et al. Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies. J Pathol 1986;150:195-203.
2. Wood CB, Gillis CR, Blumgart LH. A retrospective study of the natural history of patients with liver metastases from colorectal cancer. Clin Oncol 1976;2:285-8.
3. Hohn DC, Stagg RJ, Friedman MA, et al. A randomized trial of continuous intravenous vs. hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial. J Clin Oncol 1989;7:1646-54.
4. Kemeny N, Cohen A, Seiter K, et al. Randomized trial of hepatic arterial floxuridine, mitomycin, and carmustine vs. floxuridine alone in previously treated patients with liver metastases from colorectal cancer. J Clin Oncol 1993;11:330-5.
5. Rougier P, Laplance A, Hugier M, et al. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial. J Clin Oncol 1992;10:1112-8.
6. Wagman LD, Kemeny MM, Leong L, et al. A prospective randomized evaluation of the treatment of colorectal cancer metastatic to the liver. J Clin Oncol 1990; 8:1885-93.
7. Advanced Colorectal Cancer Meta-Analysis Project. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. J Clin Oncol 1992;10:896-903.
8. Colucci G, Maiello E, Giuliani F, Cifarelli CA, Giotta F. Carboplatin and etoposide in previously treated colorectal cancer patients. Tumori 1995;81:36-8.
9. Stuart K, Posner M, Campbell K, Huberman M. Cisplatin and chronic oral etoposide as salvage therapy for advanced colorectal carcinoma. Am J Clin Oncol 1995;18: 300-2.
10. Conti IA, Kemeny NE, Saltz LB, Andre AM, Grossano DD, Bertino JR. Continuous infusion fluorouracil/ leucovorin and bolus mitomycin-C as a salvage regimen for patients with advanced colorectal cancer. Cancer 1995;75:769-74.
11. Rothenberg ML, Eckardt JR, Kuhn JG, et al. Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer. J Clin Oncol 1996;14: 1128-35.
12. Hughes K, Scheele J, Sugarbaker PH. Surgery for colorectal cancer metastatic to the liver. Surg Clin North Am 1989;69:339-59.
13. Cady B, Stone M. The role of surgical resection of liver metastases in colorectal carcinoma. Semin Oncol 1991; 18:399-406.
14. Patt YZ. Regional hepatic arterial chemotherapy for colorectal cancer metastatic to the liver: the controversy continues. J Clin Oncol 1993;11:815-9.
15. Meta-Analysis Group in Cancer. Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. J Natl Cancer Inst 1996;88:252-8.
16. Lorenz M, Herrmann G, Kirkowa-Reimann M, et al. Temporary chemoembolization of colorectal liver metastases with degradable starch microspheres. Eur J Surg Oncol 1989;15:453-62.
17. Meakem TJ, Unger EC, Pond GD, Modiano MR, Alberts DR. CT findings after hepatic chemoembolization. J Comput Assist Tomogr 1992;16:916-20.
18. Kameyama M, Imaoka S, Fukuda I, et al. Delayed wash-out of intratumor blood flow is associated with good response to intraarterial chemoembolization for liver metastases of colorectal cancer. Surgery 1993;114: 97-101.
19. Hunt TM, Flowerdew AD, Birch SJ, Williams JD, Mullee MA, Taylor I. Prospective randomized controlled trial of hepatic arterial embolization or infusion chemotherapy with 5-fluorouracil and degradable starch microspheres for colorectal liver metastases. Br J Surg 1990;77:779-82.
20. Lang EK, Brown CL. Colorectal metastases to the liver: Selective chemoembolization. Radiology 1993;189: 417-22.
21. Martinelli DJ, Wadler S, Bakal CW, et al. Utility of embolization or chemoembolization as second-line treatment in patients with advanced or recurrent colorectal carcinoma. Cancer 1994;74:1706-12.
22. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53: 457-81.
23. Borner M, Castiglione M, Triller J, et al. Considerable side-effects of chemoembolization for colorectal carcinoma metastatic to the liver. Ann Oncol 1992;3:113-5.
24. Stuart K, Posner M, Huberman M, Steele G, Stokes K. Chemoembolizationfor hepatic metastases from colorectal carcinoma [abstract]. Proc Am Soc Clin Oncol 1994;13:227.
25. Kemeny N, Niedzwiecki D, Shurgot B, Oderman P. Prognostic variables in patients with hepatic metastases from colorectal cancer. Cancer 1989;63:742-7.
26. Goslin R, Steele G Jr, Zamcheck N, Mayer R, MacIntyre J. Factors influencing survival in patients with hepatic metastases from adenocarcinoma of the colon or rectum. Dis Colon Rectum 1982;25;749-54.